Sign in
4

Changes in Ownership

HALOZYME THERAPEUTICS, INC. Filed Acc 0001159036-26-000133

Director sold 5,230 shares at an average $108.54 ($567,661)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Posard Matthew L. · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2026-10-01 Sale : show line 1 in the form 10b5-1 −730 $107.17 $78,233 58,109 D
2026-10-01 Sale : show line 2 in the form 10b5-1 −3,300 $108.45 $357,898 54,809 D
2026-10-01 Sale : show line 3 in the form 10b5-1 −1,100 $109.57 $120,526 53,709 D
2026-10-01 Sale : show line 4 in the form 10b5-1 −100 $110.04 $11,004 53,609 D
Open-market sales · 5,230 sh · avg $108.54 · $567,661
Loading xslF345X06/wk-form4_1790973495.xml…